January 17, 2018Open Access
View Full PaperLong-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Key Points
Key points are not available for this paper at this time.
Abstract
Significant differences were noted in the risk of progression between patients with IgM MGUS and those with non-IgM MGUS. Overall survival was shorter among patients with MGUS than was expected in a matched control population. (Funded by the National Cancer Institute.).